{
  "image_filename": "table_p7_det_6_004.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/table_p7_det_6_004.png",
  "image_type": "Table",
  "page_number": 7,
  "block_id": "det_6_004",
  "claim_id": "claim_004",
  "claim": "Vaccination with a higher-dose recombinant flu vaccine may induce a more robust antibody response than egg-based standard-dose vaccines.",
  "supports_claim": false,
  "explanation": "Table presenting baseline demographic and clinical characteristics of study participants stratified by vaccine type (recombinant high-dose vaccine vs egg-based standard-dose vaccine vs all vaccines), including counts and percentages for sex, race/ethnic group, preexisting illnesses, and prior influenza vaccination. does not support the claim because the table provides participants\u2019 demographic and clinical baseline characteristics and contains no data on antibody responses or immunogenicity comparisons between vaccine types.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Table presenting baseline demographic and clinical characteristics of study participants stratified by vaccine type (recombinant high-dose vaccine vs egg-based standard-dose vaccine vs all vaccines), including counts and percentages for sex, race/ethnic group, preexisting illnesses, and prior influenza vaccination.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table provides participants\u2019 demographic and clinical baseline characteristics and contains no data on antibody responses or immunogenicity comparisons between vaccine types.",
    "confidence_notes": null
  }
}